72 related articles for article (PubMed ID: 37365560)
1. HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway.
Yang G; Su F; Han BX; Su HX; Guo CH; Yu SH; Guan QL; Hou XM
Biochem Pharmacol; 2024 May; 223():116133. PubMed ID: 38494066
[TBL] [Abstract][Full Text] [Related]
2. Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway.
Zhang W; Dong J; Xu J; Qian Y; Chen D; Fan Z; Yang H; Xiang J; Xue X; Luo X; Jiang Y; Wang Y; Huang Z
Biochem Pharmacol; 2024 May; 223():116112. PubMed ID: 38458331
[TBL] [Abstract][Full Text] [Related]
3. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma.
Ji Q; Guo Y; Li Z; Zhang X
Aging (Albany NY); 2024 Mar; 16(6):5601-5617. PubMed ID: 38535989
[TBL] [Abstract][Full Text] [Related]
4. CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma.
Safaee MM; Wang EJ; Jain S; Chen JS; Gill S; Zheng AC; Garcia JH; Beniwal AS; Tran Y; Nguyen AT; Trieu M; Leung K; Wells J; Maclean JM; Wycoff K; Aghi MK
Sci Rep; 2022 Jan; 12(1):1464. PubMed ID: 35087132
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
Li J; Zhang B; Feng Z; An D; Zhou Z; Wan C; Hu Y; Sun Y; Wang Y; Liu X; Wei W; Yang X; Meng J; Che M; Sheng Y; Wu B; Wen L; Huang F; Li Y; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):28. PubMed ID: 38254206
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level.
Liu P; Xing N; Xiahou Z; Yan J; Lin Z; Zhang J
Front Immunol; 2024; 15():1368685. PubMed ID: 38510250
[TBL] [Abstract][Full Text] [Related]
7. The embryonic stem cell microenvironment inhibits mouse glioma cell proliferation by regulating the PI3K/AKT pathway.
He X; Liu J; Wang X; Liu T; Yang L; Li C; Wang C; Liu Y; Sang X; Wang Z; Lu X
Transl Cancer Res; 2021 Jan; 10(1):487-498. PubMed ID: 35116278
[TBL] [Abstract][Full Text] [Related]
8. Panoramic RNA expression of fibroblast growth factors in human glioblastoma tissues and the impact on the survival of patients.
Zhao K; Xu J; Zhao B
Oncol Lett; 2024 Jul; 28(1):317. PubMed ID: 38807663
[TBL] [Abstract][Full Text] [Related]
9. High expression of SLC27A2 predicts unfavorable prognosis and promotes inhibitory immune infiltration in acute lymphoblastic leukemia.
Lu L; Li J; Zheng Y; Luo L; Huang Y; Hu J; Chen Y
Transl Oncol; 2024 Jul; 45():101952. PubMed ID: 38640787
[TBL] [Abstract][Full Text] [Related]
10. Current Status and Future Perspective in Glioma Invasion Research.
Ohnishi T
Brain Sci; 2024 Mar; 14(4):. PubMed ID: 38671961
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop.
Qiu W; Guo Q; Guo X; Wang C; Li B; Qi Y; Wang S; Zhao R; Han X; Du H; Zhao S; Pan Z; Fan Y; Wang Q; Gao Z; Li G; Xue H
J Nanobiotechnology; 2023 Jul; 21(1):233. PubMed ID: 37481646
[TBL] [Abstract][Full Text] [Related]
12. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Shi Y; Huang J; Hu Y; Shen Y
BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
[TBL] [Abstract][Full Text] [Related]
13. ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells.
Di Molfetta D; Cannone S; Greco MR; Caroppo R; Piccapane F; Carvalho TMA; Altamura C; Saltarella I; Tavares Valente D; Desaphy JF; Reshkin SJ; Cardone RA
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445810
[TBL] [Abstract][Full Text] [Related]
14. Genetic inactivation of the Carnitine/Acetyl-Carnitine mitochondrial carrier of Yarrowia lipolytica leads to enhanced odd-chain fatty acid production.
Messina E; de Souza CP; Cappella C; Barile SN; Scarcia P; Pisano I; Palmieri L; Nicaud JM; Agrimi G
Microb Cell Fact; 2023 Jul; 22(1):128. PubMed ID: 37443049
[TBL] [Abstract][Full Text] [Related]
15. Targeted cross-linker delivery for the in situ mapping of protein conformations and interactions in mitochondria.
Chen Y; Zhou W; Xia Y; Zhang W; Zhao Q; Li X; Gao H; Liang Z; Ma G; Yang K; Zhang L; Zhang Y
Nat Commun; 2023 Jun; 14(1):3882. PubMed ID: 37391416
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma.
Sun Y; Mu G; Xue Z; Li X; Lin X; Han M
J Transl Med; 2023 Jun; 21(1):424. PubMed ID: 37386497
[No Abstract] [Full Text] [Related]
17. SUMF1 overexpression promotes tumorous cell growth and migration and is correlated with the immune status of patients with glioma.
Zhang P; Liu Z; Wang YY; Luo HJ; Yang CZ; Shen H; Wu HT; Li JH; Zhao HX; Ran QS
Aging (Albany NY); 2024 Mar; 16(5):4699-4722. PubMed ID: 38460946
[TBL] [Abstract][Full Text] [Related]
18. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X
BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
